Log in to search using one of your social media accounts:

 

Glenmark, Evestra ink deal to develop generic NuvaRing
Glenmark Pharmaceuticals and Evestra said today that the companies inked a development, license and commercialization deal for a generic version of Merck’s NuvaRing. Development of the etonogestrel/ethinyl estradiol contraceptive is under way, according to the companies, and they plan to file an Abbreviated New Drug Application in fiscal 2019. Get the full story at our sister site, Drug Delivery Business News. The post Glenmark, Evestra ink deal to develop generic NuvaRing appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - March 2, 2017 Category: Medical Equipment Authors: Sarah Faulkner Tags: Drug-Device Combinations Research & Development Wall Street Beat Women's Health Evestra Glenmark Pharmaceuticals Source Type: news

Local biopharmaceutical company strikes deal with global player
San Antonio-based Evestra Inc. has struck a deal with a global pharmaceutical company that could open a world of new business opportunities. It ’s entered into a strategic development, licensing and commercialization agreement with Glenmark Pharmaceuticals to develop and market a generic version of Merck& Co. Inc. ’s NuvaRing birth control product. Evestra — an emerging player in biopharmaceutical research and development with a therapeutic focus on women’s health care — plans to develop… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - March 1, 2017 Category: Biotechnology Authors: W. Scott Bailey Source Type: news

Local biopharmaceutical company strikes deal with global player
San Antonio-based Evestra Inc. has struck a deal with a global pharmaceutical company that could open a world of new business opportunities. It ’s entered into a strategic development, licensing and commercialization agreement with Glenmark Pharmaceuticals to develop and market a generic version of Merck& Co. Inc. ’s NuvaRing birth control product. Evestra — an emerging player in biopharmaceutical research and development with a therapeutic focus on women’s health care — plans to develop… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - March 1, 2017 Category: American Health Authors: W. Scott Bailey Source Type: news

Meet 10 Women Who Rushed To Get An IUD Before Inauguration Day
Since the morning of November 9, when it was clear that Donald Trump would become the 45th president, droves of women have gone to their gynecologists seeking low-cost, long-acting reversible contraception before Trump’s inauguration ― and before the GOP dismantles the Affordable Care Act.  Planned Parenthood reports that the demand for IUDs has gone up 900 percent since the election. And women’s health care providers say they have heard from women who are frightened about what the next four years will bring for their reproductive rights.  Some got their IUDs and implants months ago, and others...
Source: Healthy Living - The Huffington Post - January 18, 2017 Category: Consumer Health News Source Type: news

NUVARING (Etonogestrel And Ethinyl Estradiol) Insert, Extended Release [A-S Medication Solutions]
Updated Date: Dec 9, 2016 EST (Source: DailyMed Drug Label Updates)
Source: DailyMed Drug Label Updates - December 9, 2016 Category: Drugs & Pharmacology Source Type: news

19 Women On Why Birth Control Is So Damn Important
Birth control is an essential aspect of many women’s health care ― and with the threat of losing affordable access to it under the Trump and Pence administration, women are extra eager to celebrate it.   Whether it’s an IUD, the pill, the implant or the NuvaRing, women all over the country know that their birth control routines are much more than “nitty gritty” details of their lives. (Sorry, Paul Ryan!) In honor of the full lives that access to contraception allows women to live, non-profit online birth control support network Bedsider started the hashtag #ThxBirthControl on W...
Source: Healthy Living - The Huffington Post - November 16, 2016 Category: Consumer Health News Source Type: news

NuvaRing (Etonogestrel, Ethinyl Estradiol Vaginal Ring) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - May 17, 2016 Category: Drugs & Pharmacology Source Type: news

NUVARING (Etonogestrel And Ethinyl Estradiol) Insert, Extended Release [Central Texas Community Health Centers]
Updated Date: Feb 11, 2016 EST (Source: DailyMed Drug Label Updates)
Source: DailyMed Drug Label Updates - February 11, 2016 Category: Drugs & Pharmacology Source Type: news

Is Your Birth Control as Safe as You Think?
Since NuvaRing hit the market, more than 700 women have filed lawsuits, claiming it has caused potentially life-threatening blood clots. The battle may change the way millions of women prevent pregnancy. (Source: WebMD Health)
Source: WebMD Health - December 21, 2015 Category: Consumer Health News Source Type: news

Sweetening the pill: could some birth-control methods kill you?
A documentary film is seeking funds on Kickstarter to investigate the side-effects of female contraceptives such as NuvaRing and Laryna. The Guardian (Source: Society for Endocrinology)
Source: Society for Endocrinology - June 22, 2015 Category: Endocrinology Source Type: news

Lawsuits raise questions about NuvaRing
Erika Langhart had a zest for life. By the time she finished college she had already visited 37 countries. After graduating from college she was working in Washington and thinking about going to law school. Her life was full of promise, but all that ... (Source: WDSU.com - Health)
Source: WDSU.com - Health - April 7, 2015 Category: Consumer Health News Source Type: news

Families, lawsuits, raise questions about NuvaRing
(Source: CNN.com - Health)
Source: CNN.com - Health - April 7, 2015 Category: Consumer Health News Source Type: news

NuvaRing Lawsuit Attorneys at The Oliver Law Group Comment on CNN...
NuvaRing Deaths, Injuries Detailed by CNN Series Echo Allegations Contained in Thousands of NuvaRing Lawsuits, According to The Oliver Law Group.(PRWeb June 04, 2014)Read the full story at http://www.prweb.com/releases/2014/06/prweb11917532.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - June 5, 2014 Category: Pharmaceuticals Source Type: news

NuvaRing® MDL Lawsuit Update (MDL 1964): NuvaRing®...
Kristine K. Kraft, Plaintiffs' Liaison Counsel and Co-Lead Counsel in the NuvaRing® MDL, provides an update on the NuvaRing® Multidistrict Litigation (MDL 2385), particularly that the...(PRWeb March 27, 2014)Read the full story at http://www.prweb.com/releases/2014/03/prweb11712106.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - March 28, 2014 Category: Pharmaceuticals Source Type: news

Deadline on $100 Million NuvaRing Lawsuit Settlement Moved To March...
Merck & Co. Has Agreed to Pay $100 Million to Settle Thousands of NuvaRing Blood Clot Lawsuits Now Pending in State and Federal Courts, But it is Contingent on 95% Approval of Women Plaintiffs.(PRWeb March 18, 2014)Read the full story at http://www.prweb.com/releases/2014/03/prweb11680122.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - March 18, 2014 Category: Pharmaceuticals Source Type: news

NuvaRing Lawsuit News: The Rottenstein Law Group LLP Notes Extension...
The firm is currently offering free case consultations to women who allege that they sustained injuries from the contraceptive.(PRWeb March 17, 2014)Read the full story at http://www.prweb.com/releases/nuvaring/lawsuit/prweb11670994.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - March 18, 2014 Category: Pharmaceuticals Source Type: news

NuvaRing® MDL Lawsuit Update (MDL 1964): NuvaRing®...
Kristine K. Kraft, Plaintiffs' Liaison Counsel and Co-Lead Counsel in the NuvaRing® MDL, provides an update on the NuvaRing® Multidistrict Litigation (MDL 2385), particularly that the...(PRWeb March 13, 2014)Read the full story at http://www.prweb.com/releases/2014/03/prweb11661572.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - March 13, 2014 Category: Pharmaceuticals Source Type: news

Merck to Settle Contraceptive Product-Liability Lawsuits
Merck agreed to pay $100 million to resolve all product-liability lawsuits alleging that the company's NuvaRing contraceptive caused blood clots which in some cases were fatal or led to heart attacks. (Source: WSJ.com: Health)
Source: WSJ.com: Health - February 10, 2014 Category: Pharmaceuticals Tags: PAID Source Type: news

NuvaRing® Lawsuit Update: $100 Million Settlement Reached in...
Roger Denton, Plaintiffs' Lead Counsel and one of the lead negotiators for the plaintiffs in the NuvaRing® MDL, reports that a $100 Million settlement has been reached with Merck to settle...(PRWeb February 09, 2014)Read the full story at http://www.prweb.com/releases/2014/02/prweb11566469.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - February 9, 2014 Category: Pharmaceuticals Source Type: news

Merck Settles Nuvaring Litigation Commenced by Attorney Jason T. Brown...
Attorney Jason T. Brown whose practice focuses on Mass Torts and Class Actions confirmed that the Mult-District Mass Tort Litigation concerning blood clots allegedly caused from the Nuvaring has...(PRWeb February 07, 2014)Read the full story at http://www.prweb.com/releases/2014/02/prweb11566373.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - February 8, 2014 Category: Pharmaceuticals Source Type: news

NuvaRing Lawsuit and Settlement Update from the Skikos Firm, New...
A growing number of NuvaRing users have filed lawsuits alleging blood clots and related side effects such as stroke, pulmonary embolism, and DVT. Readers can learn more at...(PRWeb January 15, 2014)Read the full story at http://www.prweb.com/releases/2014/01/prweb11482791.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - January 15, 2014 Category: Pharmaceuticals Source Type: news

NUVARING (Etonogestrel And Ethinyl Estradiol) Insert, Extended Release [Organon USA Inc.]
Updated Date: Jan 9, 2014 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) - January 9, 2014 Category: Drugs & Pharmacology Source Type: news

What is NuvaRing (vaginal ring)? How to use NuvaRing
The NuvaRing is a hormonal contraceptive device for women. The device is a flexible plastic ring which is placed into the vagina. The NuvaRing releases the hormones progestin and estrogen into the body, which prevents the ovaries from producing mature eggs. A NuvaRing is typically worn for three weeks, after which it should be removed - to allow menstruation. A regular menstrual period will typically start within two or three days of removing the ring. After a one week break a new ring can be inserted. NuvaRing is manufactured by the pharmaceutical giant Merck... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - September 2, 2013 Category: Consumer Health News Tags: Women's Health / Gynecology Source Type: news

d'Oliveira & Associates Releases NuvaRing Infographic...
The personal injury law firm has issued an infographic to inform NuvaRing users about current lawsuits that have alleged the device has caused serious side effects.(PRWeb March 02, 2013)Read the full story at http://www.prweb.com/releases/2013/3/prweb10488926.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - March 3, 2013 Category: Pharmaceuticals Source Type: news

d’Oliveira & Associates Provides New Up to Date Information to...
d’Oliveira & Associates has added three subpages to its NuvaRing webpage.(PRWeb February 04, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10388092.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - February 5, 2013 Category: Pharmaceuticals Source Type: news